Donegal Group Cl B (DGICB) 17.45 $DGICB Donegal Group

New Post Public Reply Private Reply Replies (0) Message Board

Sep 3, 2016 at 9:08 PM

Donegal Group Cl B (DGICB) 17.45 $DGICB

Donegal Group Inc. to Present at the Keefe, Bruyette & Woods 2016 Insurance Conference
GlobeNewswire - Thu Aug 25, 8:00AM CDT
Donegal Group Inc. (NASDAQ

GICA) and (NASDAQ

GICB) announced today that Kevin G. Burke, President and Chief Executive Officer, and Jeffrey D. Miller, Executive Vice President and Chief Financial Officer, are scheduled to present at the Keefe, Bruyette & Woods 2016 Insurance Conference on Wednesday, September 7, 2016 at 2:30 p.m. ET in New York, New York. The presentation will be broadcast live over the Internet through the following link: http://wsw.com/webcast/kbw36/dgica.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces Second Quarter 2016 Webcast
GlobeNewswire - Wed Jun 15, 8:45AM CDT
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) announced that the Company plans to hold a live webcast on Tuesday, July 26, 2016, at 11:00AM Eastern Time, to discuss its results for the second quarter ended June 30, 2016. The Company will release its quarterly results on this same date, prior to the opening of regular trading on the NASDAQ Stock Market. You may listen to the webcast by accessing the event link on the Company's investor website at http://investors.donegalgroup.com.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Insurance Selects VUE Software to Transform Producer Digital Experience
PR Newswire - Mon May 02, 10:47AM CDT
VUE Software announced today that Pennsylvania-based P&C Insurer Donegal Insurance Group is optimizing its Producers' digital experience with VUE Software's Distribution Management Suite. "Enhancing our distribution technology will provide our producers with ready access to essential business information and will improve customer interaction," said Sanjay Pandey, Chief Information Officer at Donegal Insurance Group.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Increases Quarterly Dividend
GlobeNewswire - Thu Apr 21, 1:15PM CDT
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) reported that its board of directors declared a regular quarterly cash dividend of $.1375 per share of the Company's Class A common stock and $.12 per share of the Company's Class B common stock. The dividends are payable on May 16, 2016 to stockholders of record as of the close of business on May 2, 2016. These dividends represent percentage increases of 1.9% for the Company's Class A common stock and 2.1% for the Company's Class B common stock compared to the previous quarterly cash dividend rates.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal posts 1Q profit
Automated Insights - Wed Apr 20, 7:37AM CDT
MARIETTA, Pa. (AP) _ Donegal Group Inc. (DGICA) on Wednesday reported first-quarter earnings of $11.8 million.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces First Quarter 2016 Results
GlobeNewswire - Wed Apr 20, 7:00AM CDT
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) today reported its financial results for the first quarter of 2016. Highlights included:
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces Fourth Quarter 2015 Webcast
GlobeNewswire - Fri Jan 15, 8:15AM CST
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) announced that the Company will hold a live webcast on Friday, February 19, 2016, at 11:00AM Eastern Time, to discuss its results for the fourth quarter and year ended December 31, 2015. The Company will release its quarterly results on this same date, prior to the opening of regular trading on the NASDAQ Stock Market. You may listen to the webcast by accessing the event link on the Company's investor website at http://investors.donegalgroup.com.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. and Donegal Mutual Insurance Company Purchase Shepard Shares
GlobeNewswire - Tue Dec 22, 1:00PM CST
Donegal Group Inc. ("DGI"

(NASDAQ

GICA) (NASDAQ

GICB) today reported that it, along with Donegal Mutual Insurance Company ("Donegal Mutual"

, the holder of majority voting control of DGI, purchased 3,675,000 shares of DGI Class A common stock and 400,000 shares of DGI Class B common stock from Gregory M. Shepard at a price of $16.50 per Class A share and $23.50 per Class B share. DGI purchased 2,000,000 of the Class A shares, and Donegal Mutual purchased 1,675,000 of the Class A shares and all 400,000 of the Class B shares. As a result of these purchases, Donegal Mutual holds approximately 73.8% of the total voting power of DGI's common stock outstanding, and Mr. Shepard owns no shares of either class.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05), MTB: 117.34 (+0.02)

Donegal Group Inc. Announces Quarterly Dividend
GlobeNewswire - Thu Dec 17, 3:30PM CST
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) reported that its board of directors declared a regular quarterly cash dividend of $.1350 per share of the Company's Class A common stock and $.1175 per share of the Company's Class B common stock. The dividends are payable on February 16, 2016 to stockholders of record as of the close of business on February 2, 2016.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces Results for Third Quarter and First Nine Months of 2015
GlobeNewswire - Fri Oct 23, 7:00AM CDT
Donegal Group Inc. (NASDAQ

GICA) (Nasdaq

GICB) today reported its financial results for the third quarter and first nine months of 2015. Significant developments include:
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces Third Quarter 2015 Webcast
GlobeNewswire - Tue Sep 22, 8:00AM CDT
Donegal Group Inc. (Nasdaq

GICA) (Nasdaq

GICB) announced that the Company will hold a live webcast on Friday, October 23, 2015, at 11:00AM Eastern Time, to discuss its results for the third quarter ended September 30, 2015. The Company will release its quarterly results on this same date, prior to the opening of regular trading on the NASDAQ Stock Market. You may listen to the webcast by accessing the event link on the Company's investor website at http://investors.donegalgroup.com.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. to Present at Keefe, Bruyette & Woods 2015 Insurance Conference
GlobeNewswire - Mon Aug 24, 8:37AM CDT
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) announced today that the Company will participate in the Keefe, Bruyette & Woods 2015 Insurance Conference. Kevin G. Burke, President and Chief Executive Officer, and Jeffrey D. Miller, Executive Vice President and Chief Financial Officer, are scheduled to present on Wednesday, September 9, 2015, at 4:15 p.m. (Eastern). If you are unable to attend the conference, you may listen to the presentation live over the Internet through a link on the Investors page of the Company's website at http://investors.donegalgroup.com.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces Significantly Improved Second Quarter and First Half 2015 Results
GlobeNewswire - Tue Jul 28, 7:00AM CDT
Donegal Group Inc. (NASDAQ

GICA) (NASDAQ

GICB) today reported its financial results for the second quarter and first half of 2015. Highlights include:
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Donegal Group Inc. Announces Kevin G. Burke Appointed President and Chief Executive Officer
GlobeNewswire - Fri Jul 17, 3:15PM CDT
Donegal Group Inc. ("DGI"

(NASDAQ

GICA) (NASDAQ

GICB) announced today that Donald H. Nikolaus, the Chairman of the Board, President and Chief Executive Officer of DGI, which was founded in 1986 as a downstream holding company for Donegal Mutual Insurance Company ("DMIC"

, returned, effective July 16, 2015, from a temporary medical leave of absence. During that temporary medical leave of absence, Kevin G. Burke served as Acting Chief Executive Officer of DGI while Mr. Nikolaus continued to serve as Chairman of the Board and President of DGI.
DGICB: 17.45 (+1.45), DGICA: 16.13 (+0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....